August 2025 : The US FDA approved Wegovy (semaglutide 2.4 mg) for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced-calorie diet and increased physical activity
Ferroptosis of tumour neutrophils causes immune suppression in cancer
Each medication affects people differently, and it may be that your body responds to one better than the other
Electrolyte Imbalance Vomiting or diarrhea can reduce important minerals like sodium, potassium, and magnesium, which help muscles function properly
Qin and his colleagues in the Erik Jonsson School of Engineering and Computer Science and at other institutions demonstrated the approach in mice in a study published online Sept
While blood clots are not a recognized side effect of GLP-1 medications, patients should remain aware of warning signs, particularly given that obesity itself increases thrombotic risk